Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

Cited by (1,001)

Items 401–500 of 1,001

1. Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time
   Shumei Chia, Joo-Leng Low, Xiaoqian Zhang, Xue-Lin Kwang, Fui-Teen Chong, Ankur Sharma, Denis Bertrand, Shen Yon Toh, Hui Sun Leong, Matan Thangavelu Thangavelu et al. · 2017 · Nature Communications
2. Three-dimensional cell culture: from evolution to revolution
   Sharmin Alhaque, Michael Themis, Hassan Rashidi · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
3. A biomimetic 3D model of hypoxia-driven cancer progression
   Chiara Liverani, Alessandro De Vita, Silvia Minardi, Yibin Kang, Laura Mercatali, Dino Amadori, Alberto Bongiovanni, Federico La Manna, Toni Ibrahim, Ennio Tasciotti · 2019 · Scientific Reports
4. Inhibition of the PLK1‐Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer
   Zhaoliang Yu, Peng Deng, Yufeng Chen, Shini Liu, Jinghong Chen, Zihuan Yang, Jianfeng Chen, Xinjuan Fan, Peili Wang, Zerong Cai et al. · 2021 · Advanced Science
5. Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage
   Maria C. Heinz, Niek A. Peters, Koen C. Oost, Rik G.H. Lindeboom, Lisa van Voorthuijsen, Arianna Fumagalli, Mirjam C. van der Net, Gustavo de Medeiros, Joris H. Hageman, Ingrid Verlaan-Klink et al. · 2022 · Cancer Research
6. Development and application of human adult stem or progenitor cell organoids
   Maarten B. Rookmaaker, Frans Schutgens, Marianne Christina Verhaar, Hans C. Clevers · 2015 · Nature Reviews Nephrology
7. Past, Present, and Future of Brain Organoid Technology.
   Bonsang Koo, Baekgyu Choi, Hoewon Park, Ki‐Jun Yoon · 2019 · Europe PMC (PubMed Central)
8. Bioprinting of in vitro tumor models for personalized cancer treatment: a review
   Shuangshuang Mao, Yuan Pang, Tiankun Liu, Yongchun Shao, Jianyu He, Huayu Yang, Yilei Mao, Wei Sun · 2020 · Biofabrication
9. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids
   Beatriz Subtil, Kirti K. Iyer, Dennis Poel, Lotte Bakkerus, Mark A.J. Gorris, Jorge Cuenca‐Escalona, Koen van den Dries, Alessandra Cambi, Henk M.W. Verheul, I. Jolanda M. de Vries et al. · 2023 · Frontiers in Immunology
10. Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
    Elena Maria Tosca, Davide Ronchi, Daniele Facciolo, Paolo Magni · 2023 · Biomedicines
11. Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic Approaches
    Xueda Hu, Zemin Zhang · 2015 · Trends in Genetics
12. Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis
    Laura Valle · 2016 · Clinical Gastroenterology and Hepatology
13. MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids
    Xin Liu, Colin Flinders, Shannon M. Mumenthaler, Amanda B. Hummon · 2017 · Journal of the American Society for Mass Spectrometry
14. Gastrointestinal Organoids: Understanding the Molecular Basis of the Host–Microbe Interface
    David R. Hill, Jason R. Spence · 2016 · Cellular and Molecular Gastroenterology and Hepatology
15. Assessing Toxicity with Human Cell-Based In Vitro Methods
    Daniele Zink, Jacqueline Kai Chin Chuah, Jackie Y. Ying · 2020 · Trends in Molecular Medicine
16. Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD
    Martina Poletti, Kaline Arnauts, Marc Ferrante, Tamás Korcsmáros · 2020 · Journal of Crohn s and Colitis
17. “Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
    Federica Papaccio, Blanca García-Micó, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro‐Cervelló, Carolina Martínez‐Ciarpaglini, Pilar Rentero-Garrido, S. Zúñiga et al. · 2023 · Journal of Experimental & Clinical Cancer Research
18. Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids
    Marius F. Harter, Timothy Recaldin, Régine Gérard, Blandine Avignon, Yannik Bollen, Cinzia Esposito, Karolina Guja-Jarosz, Kristina Kromer, Adrian M. Filip, Julien Aubert et al. · 2023 · Nature Biomedical Engineering
19. Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
    Daisong Wang, Rémi Villenave, Nadine Stokar‐Regenscheit, Hans C. Clevers · 2025 · Nature Reviews Drug Discovery
20. The potential of organoids in urological cancer research
    Wang, Shangqian, Gao, Dong, Chen, Yu · 2017 · Nature Reviews Urology
21. Human colon organoids reveal distinct physiologic and oncogenic Wnt responses
    Birgitta E. Michels, Mohammed H. Mosa, Britta Moyo Grebbin, Diego Yepes, Tahmineh Darvishi, Johannes Hausmann, Henning Urlaub, Stefan Zeuzem, Hans Michael Kvasnicka, Thomas Oellerich et al. · 2019 · The Journal of Experimental Medicine
22. Current Status of Patient-Derived Ovarian Cancer Models
    Yoshiaki Maru, Yoshitaka Hippo · 2019 · Cells
23. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids
    Gianluca Costamagna, Giacomo P. Comi, Stefania Paola Corti · 2021 · International Journal of Molecular Sciences
24. 3D tumor angiogenesis models: recent advances and challenges
    Sharath Mohan Bhat, Vaishnavi Ashok Badiger, Sampara Vasishta, Juhi Chakraborty, Prasad Seetharam, Sourabh Ghosh, Manjunath Bandu Joshi · 2021 · Journal of Cancer Research and Clinical Oncology
25. Organoid Models for Precision Cancer Immunotherapy
    Caiping Sun, Huanrong Lan, Xingliang Fang, Xiaoyun Yang, Ketao Jin · 2022 · Frontiers in Immunology
26. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
    Talya L. Dayton, Nicolas Alcala, Laura Moonen, Lisanne den Hartigh, Veerle Geurts, Lise Mangiante, Lisa M. V. Lap, Antonella F. M. Dost, Joep Beumer, Sonja Levy et al. · 2023 · Cancer Cell
27. Organoids: An intermediate modeling platform in precision oncology
    Mingzhu Jin, Run-Run Han, Guanzhong Qiu, Xiang-Chun Ju, Ge Lou, Weilin Jin · 2017 · Cancer Letters
28. Proposed Molecular and miRNA Classification of Gastric Cancer
    Lara Alessandrini, Melissa Manchi, Vallì De Re, Riccardo Dolcetti, Vincenzo Canzonieri · 2018 · International Journal of Molecular Sciences
29. The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
    Anastasia C. Hepburn, Rebecca E. Steele, Rajan Veeratterapillay, Laura Wilson, Evangelia E. Kounatidou, Amy Barnard, P. Berry, James Cassidy, Mohammad Moad, A El‐Sherif et al. · 2019 · Oncogene
30. Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments
    Qian Wang, Fangwei Yuan, Xianglin Zuo, Ming Li · 2025 · Cell Death Discovery
31. Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
    Serena Mazzucchelli, F Piccotti, Raffaele Allevi, Marta Truffi, Luca Sorrentino, L. Russo, Manuela Agozzino, Lorena Signati, Arianna Bonizzi, Laura Villani et al. · 2019 · Biological Procedures Online
32. Organoids are promising tools for species‐specific in vitro toxicological studies
    Justyna Augustyniak, Alessia Bertero, Teresa Coccini, Diego Baderna, Leonora Bużańska, F. Caloni · 2019 · Journal of Applied Toxicology
33. Standardized GMP-compliant scalable production of human pancreas organoids
    Marta Dossena, Roberta Piras, Alessandro Cherubini, Mario Barilani, Erica Dugnani, F. Salanitro, Till Moreth, Francesco Pampaloni, Lorenzo Piemonti, Lorenza Lazzari · 2020 · Stem Cell Research & Therapy
34. Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer
    Jialong Zhu, Linlin Ji, Yitian Chen, Huiyu Li, Mengxi Huang, Zhe Dai, Jing Wang, Dan Xiang, Gongbo Fu, Zengjie Lei et al. · 2023 · Cell Death Discovery
35. Organoids as Models for Neoplastic Transformation
    James T. Neal, Calvin Jay Kuo · 2016 · Annual Review of Pathology Mechanisms of Disease
36. Establishment of patient-derived tumor spheroids for non-small cell lung cancer
    Zhang, Zengli, Wang, Huiqian, Ding, Qifeng, Xing, Yufei, Xu, Zhonghua, Lu, Chun, Luo, Dongdong, Xu, Longjiang, Xia, Wei, Zhou, Caicun et al. · 2018 · PLOS ONE
37. Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids
    Misun Park, Junhye Kwon, Hye‐Jin Shin, Sun Moon, Sang Wun Kim, Ui Sup Shin, Young‑Hoon Han, Younjoo Kim · 2020 · International Journal of Oncology
38. Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials
    C. Norman Coleman, Geoff Stuart Higgins, J. Martin Brown, Michael A. Baumann, David G. Kirsch, Henning Willers, Pataje G.S. Prasanna, Mark W. Dewhirst, Eric J. Bernhard, Mansoor M. Ahmed · 2016 · Clinical Cancer Research
39. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks
    Nancy Palechor-Ceron, Ewa Krawczyk, Aleksandra Dakic, Vera Simić, Hang Yuan, Jan K. Blancato, Weisheng Wang, Fleesie A. Hubbard, Yun‐Ling Zheng, Hancai Dan et al. · 2019 · Cells
40. Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens
    Raphaëlle Servant, Michele Garioni, Tatjana Vlajnic, Melanie Blind, Heike Pueschel, David Christian Müller, Tobias Zellweger, Arnoud J. Templeton, Andrea Garofoli, Sina Maletti et al. · 2021 · The Journal of Pathology
41. A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS
    Xiaohua Duan, Tuo Zhang, Lingling Feng, Neranjan de Silva, Benjamin C. Greenspun, Xing Wang, Jenna E. Moyer, M. Laura Martin, Rohit Chandwani, Olivier Elemento et al. · 2023 · Cell stem cell
42. Concise Review: Organoids Are a Powerful Tool for the Study of Liver Disease and Personalized Treatment Design in Humans and Animals
    Sathidpak Nantasanti Assawarachan, Alain de Bruin, Jan Jaap Rothuizen, Louis C. Penning, Baukje A. Schotanus · 2016 · Stem Cells Translational Medicine
43. Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function
    Karin M. de Winter‐de Groot, Hettie M. Janssens, Rick T. van Uum, Johanna F. Dekkers, Gitte Berkers, Annelotte M. Vonk, Evelien Kruisselbrink, Hugo Oppelaar, Robert G.J. Vries, Hans C. Clevers et al. · 2018 · European Respiratory Journal
44. Integrated cancer tissue engineering models for precision medicine
    Michael E. Bregenzer, Eric N. Horst, Pooja Mehta, Caymen M. Novak, Shreya A. Raghavan, Catherine S. Snyder, Geeta Mehta · 2019 · PLoS ONE
45. Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
    Jungeun Lim, Hanna Ching, Jeong‐Kee Yoon, Noo Li Jeon, YongTae Kim · 2021 · Nano Convergence
46. Role of Patient-Derived Models of Cancer in Translational Oncology
    K. Idrisova, Hans‐Uwe Simon, Marina O. Gomzikova · 2022 · Cancers
47. Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer
    Sander Mertens, Maarten A. Huismans, Carla S. Veríssimo, Bas Ponsioen, René Overmeer, Natalie Proost, Olaf van Tellingen, Marieke van de Ven, Harry Begthel, Sylvia F. Boj et al. · 2023 · Cell Reports
48. Standardization of organoid culture in cancer research
    Changchun Zhou, Yuanbo Wu, Zeyu Wang, Yanli Liu, Jiaqi Yu, Weiping Wang, Sunrui Chen, Weihua Wu, Ji‐Dong Wang, Guowei Qian et al. · 2023 · Cancer Medicine
49. Drug Sensitivity Assays of Human Cancer Organoid Cultures
    Hayley E. Francies, Andrew S. Barthorpe, Anne McLaren-Douglas, William J. Barendt, Mathew J. Garnett · 2016 · Methods in molecular biology
50. Zebrafish Avatars towards Personalized Medicine—A Comparative Review between Avatar Models
    Bruna Figueiredo Costa, Marta F Estrada, Raquel Valente Mendes, Rita Fior · 2020 · Cells
51. Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
    Christian Hirt, Tijmen H. Booij, Linda Grob, Patrik Simmler, Nora C. Toussaint, David Keller, Doreen Taube, Vanessa Ludwig, Alexander Goryachkin, Chantal Pauli et al. · 2022 · Cell Genomics
52. Construction of tumor organoids and their application to cancer research and therapy
    Jiajing Lv, Xuan Du, Miaomiao Wang, Jiacan Su, Yan Wei, Can Xu · 2024 · Theranostics
53. The current landscape of 3D in vitro tumor models: what cancer hallmarks are accessible for drug discovery?
    Rodenhizer, Darren, Dean, Teresa, D'Arcangelo, Elisa, McGuigan, Alison P. · 2018 · Advanced Healthcare Materials
54. Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures
    Dirk Schumacher, Geoffroy Andrieux, Karsten Boehnke, Marlen Keil, Alessandra Silvestri, Maxine Silvestrov, Ulrich Keilholz, Johannes Haybaeck, Gerrit Erdmann, Christoph Sachse et al. · 2019 · PLoS Genetics
55. The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions
    Kelly Mitchell, Katie M. Troike, Daniel J. Silver, Justin Durla Lathia · 2020 · Neuro-Oncology
56. A 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance
    Eileen Reidy, Niamh A. Leonard, Oliver Treacy, Aideen E. Ryan · 2021 · Cancers
57. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer
    Kohta Toshimitsu, Ai Takano, Masayuki Fujii, Kazuhiro Togasaki, Mami Matano, Sirirat Takahashi, Takanori Kanai∥, Toshiro Sato · 2022 · Nature Chemical Biology
58. Human Microphysiological Models of Intestinal Tissue and Gut Microbiome
    Steven Nathaniel Steinway, Jad Saleh, Bon‐Kyoung Koo, Delphine Delacour, Deok‐Ho Kim · 2020 · Frontiers in Bioengineering and Biotechnology
59. Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications
    Vitor Rodrigues da Costa, Rodrigo Pinheiro Araldi, Hugo Vigerelli, Fernanda D’Ámelio, Thais Biude Mendes, Vivian Fonseca Gonzaga, Bruna de Oliveira Policiquio, Gabriel Avelar Colozza‐Gama, Cristiane Wenceslau Valverde, Irina Kerkis · 2021 · Cells
60. Applications of human organoids in the personalized treatment for digestive diseases
    Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma · 2022 · Signal Transduction and Targeted Therapy
61. A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer
    Sabra I. Djomehri, Boris Burman, María E. González, Shuichi Takayama, Celina Graciela Kleer · 2018 · Journal of Cell Communication and Signaling
62. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases
    Mi Jian, Li Ren, Guodong He, Qi Lin, Wentao Tang, Yijiao Chen, Jingwen Chen, Tianyu Liu, Meiling Ji, Ye Wei et al. · 2020 · Journal of Translational Medicine
63. Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns
    Yannik Bollen, Ellen Stelloo, Petra van Leenen, Myrna van den Bos, Bas Ponsioen, Bingxin Lu, Markus J. van Roosmalen, Ana C.F. Bolhaqueiro, Christopher Kimberley, Maximilian Mossner et al. · 2021 · Nature Genetics
64. 3D modeling in cancer studies
    Oula El Atat, Zahra Farzaneh, Mahsa Pourhamzeh, Fatima Taki, Ralph Joseph Abi‐Habib, Massoud Vosough, Mirvat El‐Sibai · 2021 · Human Cell
65. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues
    Mei Gao, Miranda Lin, Manisha Rao, Hannah Thompson, Kelsi Hirai, Minsig Choi, Georgios V. Georgakis, Aaron R. Sasson, Juan Carlos Bucobo, Demetrios J. Tzimas et al. · 2018 · Annals of Surgical Oncology
66. Patient-derived xenograft models of pancreatic cancer: overview and comparison with other types of models
    Garcia, Patrick L., Miller, Aubrey L., Yoon, Karina J. · 2020 · Cancers
67. The boom in mini stomachs, brains, breasts, kidneys and more
    Cassandra Willyard · 2015 · Nature
68. Organoid culture media formulated with growth factors of defined cellular activity
    Manuela Urbischek, Helena Rannikmäe, Thomas Foets, Katharina Ravn, Marko Hyvönen, Marc de la Roche · 2019 · Scientific Reports
69. Stem cells in tissues, organoids, and cancers
    Xusheng Wang · 2019 · Cellular and Molecular Life Sciences
70. Executable cancer models: successes and challenges
    Matthew A. Clarke, Jasmin Fisher · 2020 · Nature reviews. Cancer
71. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity
    Wouter L. Smit, Claudia N. Spaan, Ruben J. de Boer, Prashanthi Ramesh, Tânia Martins Garcia, Bartolomeus Joannes Meijer, Jacqueline L.M. Vermeulen, Marco Lezzerini, Alyson W. MacInnes, Jan Köster et al. · 2020 · Proceedings of the National Academy of Sciences
72. Druggable genome and precision medicine in cancer: current challenges
    Camille Dupont, Kristina Riegel, Malvika Pompaiah, Hartmut H. Juhl, Krishnaraj Rajalingam · 2021 · FEBS Journal
73. Enabling peristalsis of human colon tumor organoids on microfluidic chips
    Fang, Guocheng, Lu, Hongxu, Al-Nakashli, Russul, Chapman, Robert, Zhang, Yingqi, Ju, Lining Arnold, Lin, Gungun, Stenzel, Martina H, Jin, Dayong · 2022 · Biofabrication
74. Fusobacterium nucleatum Promotes Colorectal Cancer Cell to Acquire Stem Cell‐Like Features by Manipulating Lipid Droplet‐Mediated Numb Degradation
    Haiyang Liu, Junfeng Du, Shanshan Chao, Shuoguo Li, Huiyun Cai, Hongjie Zhang, Gang Chen, Pingsheng Liu, Pengcheng Bu · 2022 · Advanced Science
75. Immune organoids: from tumor modeling to precision oncology
    Vinh A Dao, Kanako Yuki, Yuan‐Hung Lo, Michitaka Nakano, Calvin Jay Kuo · 2022 · Trends in cancer
76. A microfluidic platform for functional testing of cancer drugs on intact tumor slices
    Rodriguez, A. D., Horowitz, L. F., Castro, K., Kenerson, H., Bhattacharjee, N., Gandhe, G., Raman, A., Monnat, R. J., Yeung, R., Rostomily, R. C. et al. · 2020 · Lab on a Chip
77. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids
    Nobuhiko Takahashi, Hirotaka Hoshi, Arisa Higa, Gen Hiyama, Hirosumi Tamura, Mayu Ogawa, Kosuke Takagi, Kazuhito Goda, Naoyuki Okabe, Satoshi Muto et al. · 2019 · Cells
78. Mathematical Models of Organoid Cultures
    Sandra Montes-Olivas, Lucia Marucci, Martin Homer · 2019 · Frontiers in Genetics
79. 3D high throughput screening and profiling of embryoid bodies in thermoformed microwell plates
    Erik Vrij, Sara Espinoza, Markus A Heilig, Alexander Kolew, Marc Schneider, Clemens van Blitterswijk, Roman K. Truckenmüller, Nicolas C. Rivron · 2016 · Lab on a Chip
80. Prostate Stem Cells and Cancer Stem Cells
    Jia J. Li, Michael M. Shen · 2018 · Cold Spring Harbor Perspectives in Medicine
81. Nanotheranostics Targeting the Tumor Microenvironment
    Catarina Roma‐Rodrigues, Inês Pombo, Luís R. Raposo, Pedro Pedrosa, Alexandra Ramos Fernandes, Pedro Viana Baptista · 2019 · Frontiers in Bioengineering and Biotechnology
82. Addressing Patient Specificity in the Engineering of Tumor Models
    Laura Jane Bray, Dietmar Werner Hutmacher, Nathalie Bock · 2019 · Frontiers in Bioengineering and Biotechnology
83. Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients
    Jing‐Hua Chen, Xiangpeng Chu, Jia‐Tao Zhang, Qiang Nie, Wen‐Fang Tang, Jian Su, Hong‐Hong Yan, Hongping Zheng, Ze‐Xin Chen, Xin Chen et al. · 2020 · Thoracic Cancer
84. Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies
    Zhenzhen Zhou, Yuan Pang, Jingyuan Ji, Jianyu He, Tiankun Liu, Liliang Ouyang, Wen Zhang, Xueli Zhang, Zhigang Zhang, Kaitai Zhang et al. · 2023 · Nature reviews. Immunology
85. Esophageal development and epithelial homeostasis
    Sanne L. Rosekrans, Bart Baan, Vanesa Muncan, Gijs R. VAN DEN BRINK · 2015 · American Journal of Physiology-Gastrointestinal and Liver Physiology
86. An ecosystem of cancer cell line factories to support a cancer dependency map
    Jesse S. Boehm, Todd R. Golub · 2015 · Nature Reviews Genetics
87. Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement
    Molly M. Morgan, Brian P. Johnson, Megan K. Livingston, Linda A. Schuler, Elaine T. Alarid, Kyung Eun Sung, David J. Beebe · 2016 · Pharmacology & Therapeutics
88. Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation
    Evelyn Fessler, Jan Paul Medema · 2016 · Trends in cancer
89. Next-Generation Liver Medicine Using Organoid Models
    Akbari, Soheil, Arslan, Nur, Senturk, Serif, Erdal, Esra · 2019 · Frontiers in Cell and Developmental Biology
90. Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology
    Nobuo Sasaki, Hans C. Clevers · 2018 · Current Opinion in Genetics & Development
91. Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids
    Joe T. Sharick, Justin J. Jeffery, Mohammad R. Karim, Christine M. Walsh, Karla Esbona, Rebecca S. Cook, Melissa C. Skala · 2019 · Neoplasia
92. Bovine colon organoids: From 3D bioprinting to cryopreserved multi-well screening platforms
    Elfi Töpfer, Anna Pasotti, Aikaterini Telopoulou, Paola Italiani, Diana Boraschi, Marie‐Ann Ewart, Colin J. Wilde · 2019 · Toxicology in Vitro
93. Organoid technology for tissue engineering
    Juan He, Xiaoyu Zhang, Xinyi Xia, Ming Han, Fei Li, Chunfeng Li, Yunguang Li, Dong Gao · 2020 · Journal of Molecular Cell Biology
94. Drug screening model meets cancer organoid technology
    Chen Liu, Tianyu Qin, Yuhan Huang, Yuan Li, Gang Chen, Chaoyang Sun · 2020 · Translational Oncology
95. The landscape of drug sensitivity and resistance in sarcoma
    Ahmad Al Shihabi, Peyton J. Tebon, Huyen Thi Lam Nguyen, Jomjit Chantharasamee, Sara Sartini, Ardalan Davarifar, Alexandra Y Jensen, Miranda B. Diaz-Infante, Hannah Cox, Alfredo Enrique Gonzalez et al. · 2024 · Cell stem cell
96. From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research
    Gat Rauner, Piyush B. Gupta, Charlotte Kuperwasser · 2025 · Nature Methods
97. The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane
    Anke Loregger, Martina Grandl, Raquel Mejías‐Luque, Michael Allgäuer, Kathrin Degenhart, Verena Haselmann, Christina Oikonomou, Pantelis Hatzis, Klaus‐Peter Janssen, Ulrich Nitsche et al. · 2015 · Science Signaling
98. Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells
    Nesrin Tüysüz, Louis van Bloois, Stieneke van den Brink, Harry Begthel, Monique M. A. Verstegen, Luis Javier Cruz, Lijian Hui, Luc J. W. van der Laan, Jeroen de Jonge, Robert G.J. Vries et al. · 2017 · Nature Communications
99. A thermo-responsive collagen-nanocellulose hydrogel for the growth of intestinal organoids
    Rodrigo Curvello, Diana Alves, Helen E. Abud, Gil Garnier · 2021 · Materials Science and Engineering C
100. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
     Emre Küçükköse, Balthasar A. Heesters, Julien Villaudy, André Verheem, Madalina G. Cercel, Susan van Hal, Sylvia F. Boj, Inne H.M. Borel Rinkes, Cornelis J.A. Punt, Jeanine M.L. Roodhart et al. · 2022 · Journal for ImmunoTherapy of Cancer